Form 4: Milestone Scientific Director and 10% Owner BP4 S.r.l. Schedules Significant Stock Sales Under 10b5-1 Plan

BP4 S.r.l., a director and 10% owner of Milestone Scientific Inc., has filed a Form 4 detailing pre-scheduled sales of 92,900 shares of common stock in July 2025 under a Rule 10b5-1 trading plan.

Summary

• BP4 S.r.l., identified as both a Director and a 10% Owner of Milestone Scientific Inc. (MLSS), reported planned sales of common stock.
• The transactions are scheduled to occur on future dates in July 2025, specifically July 3, 2025, July 7, 2025, and July 8, 2025.
• These sales are being conducted pursuant to a Rule 10b5-1(c) trading plan, indicating they were pre-arranged.
• On July 3, 2025, 50,853 shares are planned to be sold at a price of $0.6698 per share.
• On July 7, 2025, an additional 30,558 shares are planned for sale at $0.6808 per share.
• On July 8, 2025, a further 11,489 shares are planned to be sold at $0.6905 per share.
• The total number of shares planned for sale across these three transactions is 92,900.
• Following these planned transactions, BP4 S.r.l.'s beneficial ownership in Milestone Scientific Inc. will decrease to 9,308,799 shares of Common Stock, Par Value $0.001.
• The filing was signed by Dr. Pedro Palau, identified as the Liquidator for BP4 S.r.l., suggesting the entity may be undergoing liquidation or winding down its holdings.

Sentiment

Score: 3

Explanation: The sentiment is negative due to a significant insider and director systematically reducing their stake, especially given the signatory is a 'Liquidator' for the selling entity, suggesting a planned divestment or winding down of holdings. While the sales are pre-planned under Rule 10b5-1, the underlying reason for the divestment by a major shareholder is concerning.

Negatives

• A significant shareholder and director, BP4 S.r.l., is systematically reducing its stake in Milestone Scientific Inc. through pre-scheduled sales.
• The signatory for BP4 S.r.l. is identified as a 'Liquidator,' which strongly suggests the entity is divesting its holdings, potentially due to a winding-down process, signaling a lack of long-term conviction or a need for liquidity from a major investor.
• The planned sale of 92,900 shares by a 10% owner could create downward pressure on the stock price as these shares enter the market.

Risks

• The planned divestment by a significant shareholder and director could lead to negative market sentiment and increased selling pressure on Milestone Scientific Inc.'s stock.
• The indication that BP4 S.r.l. is undergoing liquidation suggests a potential complete exit from its investment in Milestone Scientific Inc., which could result in further large-scale sales in the future.
• The systematic reduction of a major insider's stake may be interpreted by investors as a lack of confidence in the company's future prospects.

Future Outlook

The document details pre-scheduled sales of common stock by a significant shareholder and director in July 2025, indicating a planned reduction in their stake.

Industry Context

This filing is specific to an insider transaction for Milestone Scientific Inc. and does not provide broader industry context or trends. Insider sales, particularly by significant shareholders or directors, are closely watched by the market as they can signal management's or large investors' views on the company's future.

Related Party Transactions

• The reported sales are by BP4 S.r.l., which is identified as both a Director and a 10% Owner of Milestone Scientific Inc., making these transactions related party dealings.

Stakeholder Impact

• Shareholders may react negatively to the planned divestment by a significant insider, potentially leading to a decrease in stock price due to perceived lack of confidence or increased supply of shares.
• The company's management might face questions regarding the reasons behind a major shareholder's decision to liquidate its position.

Key Dates

Recommendation

Keywords

Milestone Scientific, MLSS, SEC Form 4, insider trading, stock sale, beneficial ownership, Rule 10b5-1, director sale, 10% owner, liquidation, BP4 S.r.l.